Most of NFL Brain Trauma Research Donation to NIH to Go Unspent

The football league and the government agency part ways over how the money should be used.

Written byShawna Williams
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

man looks at brain scan images on computerU.S. AIR FORCE/SENIOR AIRMAN JULIANNE SHOWALTERFollowing the release of a study earlier this week that found chronic traumatic encephalopathy in 110 out of 111 former National Football League (NFL) players, the National Institutes of Health (NIH) has announced it will allow a funding agreement with the league to lapse with more than half of the money unspent.

ESPN reports that nearly five years ago, the NFL made a $30 million donation to the NIH for research on the relationship between brain disease and playing football. But the relationship between the two has been fraught; according to a congressional report released last year, the “NFL did not carry out its commitment to respect the science and prioritize health and safety,” but instead “improperly attempted to influence the grant selection process at NIH.”

In particular, the NFL, which had veto power over the grants resulting from its donation, objected to a major award to a group led by Boston University neuroscientist Robert Stern, ESPN reports. That left NIH to try to cover much of the grant with other funds.

With the funding agreement about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies